Neogen (NEOG) Cash from Operations Growth (5y) (2015 - 2026)
Neogen (NEOG) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 14.38% |
| Nov 30, 2025 | -2.78% |
| Aug 31, 2025 | -15.46% |
| May 31, 2025 | -8.49% |
| Feb 28, 2025 | -0.32% |
| Nov 30, 2024 | 19.16% |
| Aug 31, 2024 | -22.47% |
| May 31, 2024 | 5.08% |
| Feb 29, 2024 | -37.47% |
| Nov 30, 2023 | -0.97% |
| Aug 31, 2023 | 7.43% |
| May 31, 2023 | 32.17% |
| Feb 28, 2023 | -23.65% |
| Nov 30, 2022 | -32.88% |
| Aug 31, 2022 | -22.49% |
| May 31, 2022 | 6.21% |
| Feb 28, 2022 | -15.87% |
| Nov 30, 2021 | 13.99% |
| Aug 31, 2021 | 2.74% |
| May 31, 2021 | 24.59% |